-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Tenax Therapeutics, Raises Price Target to $50

Benzinga·06/12/2026 16:38:05
Listen to the news
Piper Sandler analyst Yasmeen Rahimi maintains Tenax Therapeutics (NASDAQ:TENX) with a Overweight and raises the price target from $20 to $50.